07.11.2018 17:40:14
|
NEURONES: Organic growth up 5.1% over the first nine months of 2018
PRESS INFORMATION
Heading: 3rd quarter 2018 Revenues
Nanterre, November 7, 2018 (after the closing of the stock exchange)
Organic growth up 5.1% over the first nine months of 2018
(unaudited, in euro millions) |
2017 published |
2017 restated IFRS 15 | 2018 |
growth with iso-method | of which organic |
3rd quarter revenues | 114 | 112.3 | 116.9 | + 4.1% | + 5.2% |
Total at end of September | 359 | 351.4 | 360 | + 2.4% | + 5.1% |
Achievements
On an identical scope and accounting method (IFRS 15) basis, the business activity grew 5.1% over the first 9 months of FY2018. It was very dynamic in cybersecurity, DevOps platforms, infrastructure automation, mobility, EDM and RPA type applications and digital transformation consulting.
The 3rd quarter operating margin (*) was 9.9%.
Over the first nine months, it was 8.9% of revenues (as in 2017).
(*) Unaudited and after expenses of 0.3% related to bonus shares.
Outlook
For the entire 2018 fiscal year, NEURONES maintains its forecast of more than €490 million in revenues (IFRS 15). Operating profit is forecast at a minimum of 9% of revenues.
About NEURONES
With 5,200 experts, the NEURONES group specializes in Consulting (Management, Organization and Digital) and IT Services (Infrastructures and Applications). It supports its clients in their digital transformation projects and in the upgrading their information systems.
Euronext Paris (compartment B - NRO) - Enternext Tech 40 - SRD medium values
www.neurones.net
Press Relations: Florence Gillier Communication Sabine Grosdidier Tel: +33 (0)1 41 18 85 55 sabineg@fgcom.fr | NEURONES Matthieu Vautier Tel: +33 (0)1 41 37 41 37 rp@neurones.net |
Investor Relations: NEURONES Paul-César Bonnel Tel: +33 (0)1 41 37 41 37 investisseurs@neurones.net |
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NEURONES via Globenewswire
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu NeuronesAct.mehr Nachrichten
Keine Nachrichten verfügbar. |